CEOs don’t plan to openly question Trump. Ask again if the market crashes 20%.
Early on Tuesday, dozens of corporate executives and others assembled at a Yale CEO Caucus not far from the White House just as news emerged that the Trump administration planned to potentially double ...
Top CEOs Share ‘Universal Revulsion’ to Trump—but Smile to His Face
The same business leaders who are publicly cordial to Donald Trump—even to his face—privately bemoan the havoc the ...
Fierce Pharma5d
Fierce Pharma Asia—Trump's investment policy; Pfizer's tariff mitigation plan; CMIC's stake sale
U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...
Pfizer's breast cancer drug Vepdegestrant posts mixed results in key trial
The drug, vepdegestrant, failed to meaningfully delay cancer progression for all patients enrolled in the study but met its ...
Moneyweb11m
Trump’s $1.4trn tariff threat spurs companies to seek cover
Companies across the world are looking for cover from President Donald Trump’s frenzied tariff barrage, planning for the ...
The Heartland Institute2d
Big Pharma Meets with President, Questions Remain
A much-anticipated meeting between President Donald Trump and representatives of the pharmaceutical industry took place ...
Lawmakers demand answers from RFK Jr. over Trump dinners with pharma execs
Secretary Robert F. Kennedy Jr. to disclose details about several private dinners he attended with Donald Trump and ...
Even weight loss drugs aren't safe from tariffs
Novo Nordisk (NVO), the maker of the popular diabetes and weight-loss drugs Ozempic and Wegovy, expects at least some ...